Expression of neurofibromin 1 in colorectal cancer and cetuximab resistance-Reference-Cited by-同舟云学术

Expression of neurofibromin 1 in colorectal cancer and cetuximab resistance

Published:2021-11-12 Issue:1 Volume:47 Page:
ISSN:1021-335X
Container-title:Oncology Reports
language:
Short-container-title:Oncol Rep

Author:

Tak Eunyoung¹,Kim Minhee²,Cho Youngra²,Choi Sueun²,Kim Jihun³,Han Buhm⁴,Kim Hyung-Don⁵,Jang Chloe⁴,Kim Jeong⁵,Hong Yong⁵,Kim Sun⁵,Kim Tae⁵

Affiliation:

1. Department of Convergence Medicine, Asan Medical Center, University of Ulsan College of Medicine, Songpa, Seoul 05505, Republic of Korea

2. Asan Medical Institute of Convergence Science and Technology (AMIST), Asan Medical Center, University of Ulsan College of Medicine, Songpa, Seoul 05505, Republic of Korea

3. Department of Pathology, Asan Medical Center, University of Ulsan College of Medicine, Songpa, Seoul 05505, Republic of Korea

4. Department of Biomedical Sciences, Seoul National University College of Medicine, Jongro, Seoul 03080, Republic of Korea

5. Department of Oncology, Asan Medical Center, University of Ulsan College of Medicine, Songpa, Seoul 05505, Republic of Korea

Publisher

Spandidos Publications

Subject

Cancer Research,Oncology,General Medicine

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Lasting response by vertical inhibition with cetuximab and trametinib in KRAS‐mutated colorectal cancer patient‐derived xenografts;Molecular Oncology;2023-09-03

2. Identification of Prognostic Genes and a Subtype Sensitive to Cetuximab in Colorectal Cancer;J BIOL REG HOMEOS AG;2023

3. A Digestive Cartridge Reduces Parenteral Nutrition Dependence and Increases Bowel Growth in a Piglet Short Bowel Model;Annals of Surgery;2023-03-16

4. Exosomes derived from MDR cells induce cetuximab resistance in CRC via PI3K/AKT signaling‑mediated Sox2 and PD‑L1 expression;Experimental and Therapeutic Medicine;2023-01-04